Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics
Top Cited Papers
Open Access
- 1 January 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8, 0658
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82300345)
This publication has 39 references indexed in Scilit:
- Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2020
- The Master Observational Trial: A New Class of Master Protocol to Advance Precision MedicineCell, 2020
- Advancing functional and translational microbiome research using meta-omics approachesMicrobiome, 2019
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota TransplantNew England Journal of Medicine, 2019
- Daily intake of heat-killed Lactobacillus plantarum L-137 improves inflammation and lipid metabolism in overweight healthy adults: a randomized-controlled trialEuropean Journal of Nutrition, 2019
- Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology, 2019
- Microbial genes and pathways in inflammatory bowel diseaseNature Reviews Microbiology, 2019
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileNature, 2014
- Duodenal Infusion of Donor Feces for RecurrentClostridium difficileNew England Journal of Medicine, 2013
- Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?American Journal of Gastroenterology, 2012